Co-Chairs: Stephen Marder MD; David Daniel MD
This workshop on clinical trials methodology for studies targeting negative symptoms is a continuation of a process for re-evaluating recommendations based on emerging data. This group will review new data from a number of sources including recently reported trials; studies evaluating the properties of newer instruments for measuring negative symptoms; and recent analyses from the European Union NEWMEDS data base. The group will also review the recommendations from the NEWMEDS negative symptom meeting from April, 2012.